Articles
Reviews
- Folic acid for prevention of
neural tube defects: pediatric anticipatory guidance.
Morrow JD, Kelsey K J Pediatr Health Care
1998 Mar-Apr;12(2):55-9
- The incidence of neural tube defects including
myelomeningocele, which is one of the most common
causes of infant and childhood disability, can be
substantially reduced by folic acid supplementation to
the diet of women before and during the early stages
of pregnancy. All females of childbearing age should
be taking folic acid supplements of 0.4 mg/day (400
micrograms/day) and consuming a diet rich in folate.
Because many pregnancies are unplanned,
supplementation should not await plans for pregnancy.
Because pediatric nurse practitioners are in frequent
contact with both adolescent patients and patients
whose mothers are of childbearing age, and because
pediatric nurse practitioners have an interest in
preventing neural tube defects in future pediatric
patients, they are in a good position to provide the
necessary anticipatory guidance regarding the critical
need for adequate folic acid intake by females of
childbearing age. This article discusses and includes
guidelines for providing this anticipatory
guidance.
- Folic acid in the prevention of
birth defects.
Allen WP Curr Opin Pediatr 1996
Dec;8(6):630-4
- Maternal use of folic acid prior to conception
reduces the risk for neural tube defects. In addition,
other birth defects may be prevented by the
periconceptional use of folic acid.
Homocysteine-methionine metabolism appears to be
altered in women with pregnancies affected by neural
tube defects; however, the specific mechanisms of
causation are not yet known. Fortification of flour
with folic acid has been approved by the Food and Drug
Administration, although at a level that still
requires folic acid supplementation as recommended by
the Public Health Service for all women of
childbearing age to prevent neural tube defects.
- Preventing neural tube
defects: the importance of periconceptional folic acid
supplements.
Locksmith GJ, Duff P Obstet Gynecol 1998
Jun;91(6):1027-34 locksmgj@obgyn.med.ufl.edu
- OBJECTIVE: To inform the obstetrician-gynecologist
of recent scientific evidence regarding the use of
supplemental folic acid for prevention of neural tube
defects (NTDs). DATA SOURCES: We selected English
language articles via MEDLINE published from January
1990 through February 1997, using the search terms
"folic acid" and "neural tube defect." Additional
sources were identified through cross-referencing and
through searching selected journals published from
March through October 1997. METHODS OF STUDY
SELECTION: Articles were selected on the basis of
their relevance to the relationship between folate
intake and NTD incidence, mechanisms of folate
responsive NTD formation, and folate provision
strategy. We referenced 55 papers in total.
TABULATION, INTEGRATION, AND RESULTS: The majority of
evidence demonstrates a decreased incidence of NTDs
with increased folic acid consumption. The most
convincing trials were performed in Europe among women
who were planning pregnancy by using multivitamin or
folic acid supplements. Some studies suggest that the
protective effect of folate is explained, in many
cases, not through correction of dietary deficiencies,
but through correction of metabolic defects. Other
evidence implies that it reduces NTDs by causing
abortion of affected conceptuses. Supplemental folic
acid tablets are the most proven means of improving an
individual's folate status, but ensuring compliance
with a strategy using vitamin tablets is problematic.
CONCLUSION: Women of reproductive age should be
advised to take multivitamin supplements containing
0.4 mg folic acid daily. Women with previously
affected offspring who intend to become pregnant
should take daily supplementation containing 4 mg of
folic acid in the periconceptional period to reduce
the risk of recurrence.
Books
|